Clinical performance of house-dust-mite-specific subcutaneous immunotherapy in a postmarket noninterventional setting
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2197-0378
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical performance of house-dust-mite-specific subcutaneous immunotherapy in a postmarket noninterventional setting ; day:20 ; month:10 ; year:2020 ; pages:1-4
Allergo journal international ; (20.10.2020), 1-4
- Creator
-
Zieglmayer, Petra
Mösges, Ralph
Allekotte, Silke
Weissenbaeck, Sandra
Moser, Michael
Acikel, Cengiz
Raskopf, Esther
Kramer, Matthias F.
Birkholz, Katrin
Guethoff, Sonja
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40629-020-00144-4
- URN
-
urn:nbn:de:101:1-2020120507071301026953
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zieglmayer, Petra
- Mösges, Ralph
- Allekotte, Silke
- Weissenbaeck, Sandra
- Moser, Michael
- Acikel, Cengiz
- Raskopf, Esther
- Kramer, Matthias F.
- Birkholz, Katrin
- Guethoff, Sonja
- SpringerLink (Online service)
Other Objects (12)
Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
Decreased Basophil Activation against House Dust Mite after Japanese Cedar Pollen Subcutaneous Immunotherapy: A Retrospective Study
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
House dust mite immunotherapy in Germany: real-world adherence to a subcutaneous allergoid and a sublingual tablet
Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
Tolerability of an Immunologically Enhanced Subcutaneous Immunotherapy Preparation in Patients Treated with Concomitant Allergy Immunotherapy: A Non-Interventional Observational Study
Biology of house dust mites and storage mites
Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial
Severity and disease control before house dust mite immunotherapy initiation: ANTARES a French observational survey
Allergens from house dust and storage mites
New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets
Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
Decreased Basophil Activation against House Dust Mite after Japanese Cedar Pollen Subcutaneous Immunotherapy: A Retrospective Study
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
House dust mite immunotherapy in Germany: real-world adherence to a subcutaneous allergoid and a sublingual tablet
Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
Tolerability of an Immunologically Enhanced Subcutaneous Immunotherapy Preparation in Patients Treated with Concomitant Allergy Immunotherapy: A Non-Interventional Observational Study
Biology of house dust mites and storage mites
Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial
Severity and disease control before house dust mite immunotherapy initiation: ANTARES a French observational survey
Allergens from house dust and storage mites
New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets
Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
Decreased Basophil Activation against House Dust Mite after Japanese Cedar Pollen Subcutaneous Immunotherapy: A Retrospective Study
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
House dust mite immunotherapy in Germany: real-world adherence to a subcutaneous allergoid and a sublingual tablet
Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
Tolerability of an Immunologically Enhanced Subcutaneous Immunotherapy Preparation in Patients Treated with Concomitant Allergy Immunotherapy: A Non-Interventional Observational Study
Biology of house dust mites and storage mites
Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial
Severity and disease control before house dust mite immunotherapy initiation: ANTARES a French observational survey
Allergens from house dust and storage mites